UBXD2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-29947
Key Product Details
Species Reactivity
Human
Applications
Immunoprecipitation
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Between 458 and 508
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for UBXD2 Antibody
Immunoprecipitation:[NBP3-29947]-
Immunoprecipitation:[NBP3-29947]-Detection of human UBXN4 by western blot of immunoprecipitates. Samples: Whole cell lysate from 293T cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-UBXN4 antibody used for IP at 6 µg per reaction. UBXN4 was also immunoprecipitated by rabbit anti-UBXN4 antibody. For blotting immunoprecipitated UBXN4, was used at 0. 4 mg/ml0. Detection: Chemiluminescence with an exposure time of 30 seconds.Applications for UBXD2 Antibody
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
Tris-citrate/phosphate pH 7 -8.
Preservative
0.09% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: UBXD2
Alternate Names
Erasin, FLJ23318, KIAA0242KIAA2042, UBX domain containing 2, UBX domain protein 4, UBX domain-containing 1, UBX domain-containing 2, UBX domain-containing protein 2, UBX domain-containing protein 4, UBXD2, UBXDC1
Gene Symbol
UBXN4
Additional UBXD2 Products
Product Specific Notices for UBXD2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...